Nadler Financial Group, Inc. Seelos Therapeutics, Inc. Transaction History

Nadler Financial Group, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Jan 08, 2020	SELL	$0.72 - $1.52 $9,360 - $19,760	-13,000 Closed	0 $0
Q3 2019 Oct 03, 2019	BUY	$0.92 - $2.15 $11,960 - $27,950	13,000 New	13,000 $12,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $341M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nadler Financial Group, Inc. with notifications on news.